Article
FDA panel urges Acrotech to speed up study on cancer drugs
Rating:
0.0
Views:
23
Likes:
1
Library:
1
A panel of independent experts to the U.S. health regulator urged Acrotech Biopharma to work with the agency to bring forward the date for releasing trial data that could confirm benefits of the company's blood cancer drugs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value